Department of Pediatrics, University Hospital of North-Norway, NO-9038 Tromsø, Norway.
Carcinogenesis. 2011 Jul;32(7):1005-12. doi: 10.1093/carcin/bgr073. Epub 2011 May 13.
The MYCN oncogene is frequently amplified in neuroblastoma. It is one of the most consistent markers of bad prognosis for this disease. Dickkopf-3 (DKK3) is a secreted protein of the DKK family of Wnt regulators. It functions as a tumor suppressor in a range of cancers, including neuroblastoma. MYCN was recently found to downregulate DKK3 mRNA. In this study, we show that MYCN knockdown in MYCN-amplified (MNA) neuroblastoma cell lines increases secretion of endogenous DKK3 to the culture media. MicroRNAs (miRNAs) are ∼20 nt long single-stranded RNA molecules that downregulate messenger RNAs by targeting the 3' untranslated region (3'UTR). Many miRNAs regulate genes involved in the pathogenesis of cancer and are extensively deregulated in different tumors. Using miRNA target prediction software, we found several MYCN-regulated miRNAs that could target the 3'UTR sequence of DKK3, including mir-92a, mir-92b and let-7e. Luciferase expression from a reporter vector containing the DKK3-3'UTR was decreased when this construct was cotransfected with mir-92a, mir-92b or let-7e in HEK293 cells. Mutation of the mir-92 seed sequence in the 3'UTR completely rescued the observed decrease in reporter expression when cotransfected with mir-92a and mir-92b. Antagomir and miRNA-mimic transfections in neuroblastoma cell lines confirmed that DKK3 secretion to the culture media is regulated by mir-92. Consistent with reports from other cancers, we found DKK3 to be expressed in the endothelium of primary neuroblastoma samples and to be absent in tumors with MYCN amplification. Our data demonstrate that MYCN-regulated miRNAs are able to modulate the expression of the tumor suppressor DKK3 in neuroblastoma.
MYCN 癌基因在神经母细胞瘤中经常扩增。它是该疾病预后不良的最一致标志物之一。Dickkopf-3(DKK3)是 Wnt 调节因子 DKK 家族的一种分泌蛋白。它在多种癌症中作为肿瘤抑制因子发挥作用,包括神经母细胞瘤。最近发现 MYCN 下调 DKK3 mRNA。在这项研究中,我们表明,在 MYCN 扩增(MNA)神经母细胞瘤细胞系中敲低 MYCN 会增加内源性 DKK3 向培养基中的分泌。微小 RNA(miRNA)是长约 20 个核苷酸的单链 RNA 分子,通过靶向 3'非翻译区(3'UTR)来下调信使 RNA。许多 miRNA 调节参与癌症发病机制的基因,并且在不同的肿瘤中广泛失调。使用 miRNA 靶标预测软件,我们发现了几个可以靶向 DKK3 3'UTR 序列的 MYCN 调节 miRNA,包括 mir-92a、mir-92b 和 let-7e。当将包含 DKK3-3'UTR 的报告载体与 HEK293 细胞中的 mir-92a、mir-92b 或 let-7e 共转染时,该构建体的荧光素酶表达降低。当与 mir-92a 和 mir-92b 共转染时,3'UTR 中 mir-92 种子序列的突变完全挽救了观察到的报告基因表达的降低。在神经母细胞瘤细胞系中的反义寡核苷酸和 miRNA 模拟转染证实,DKK3 分泌到培养基中受 mir-92 调节。与其他癌症的报告一致,我们发现 DKK3 在原发性神经母细胞瘤样本的内皮细胞中表达,而在 MYCN 扩增的肿瘤中不存在。我们的数据表明,MYCN 调节的 miRNA 能够调节神经母细胞瘤中肿瘤抑制因子 DKK3 的表达。